Valentina Boni
Northern Essex Community College(US)Agostino Gemelli University Polyclinic(IT)Hospital Universitario Dexeus(ES)Istituto Oncologico Veneto(IT)Hospital Universitario Quirónsalud Madrid(ES)Hospital Quirónsalud Barcelona(ES)Molecular Oncology (United States)(US)University of the Sacred Heart(JP)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Cancer Immunotherapy and Biomarkers, Cancer Treatment and Pharmacology, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children(2018)2,654 cited
- → HER kinase inhibition in patients with HER2- and HER3-mutant cancers(2018)769 cited
- → Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study(2019)550 cited
- → Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial(2020)439 cited
- → Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial(2019)425 cited
- → Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study